Circulating bioactives resulting from totum-854 absorption in humans protects primary human endothelial cells against lipotoxicity: lessons from an original ex vivo clinical trial - INRAE - Institut national de recherche pour l’agriculture, l’alimentation et l’environnement Access content directly
Journal Articles Journal of Hypertension -Supplement- Year : 2023

Circulating bioactives resulting from totum-854 absorption in humans protects primary human endothelial cells against lipotoxicity: lessons from an original ex vivo clinical trial

Fabien Wauquier
  • Function : Author
  • PersonId : 1006164
Doriane Ripoche
  • Function : Author
Line Boutin-Wittrant
  • Function : Author
Yolanda F Otero
  • Function : Author
  • PersonId : 1098194
Florian Le Joubioux
  • Function : Author
  • PersonId : 1098191
Thierry Maugard
  • Function : Author
Véronique Roux
  • Function : Author
Nicolas Macian
Gisèle Pickering
  • Function : Author
  • PersonId : 1036256
Maxime Bargetto
  • Function : Author
Véronique Sapone
  • Function : Author
Murielle Cazaubiel
  • Function : Author
Sébastien Peltier
  • Function : Author
  • PersonId : 1098192
Pascal Sirvent
  • Function : Author
  • PersonId : 1098193
Yohann Wittrant
No file

Dates and versions

hal-04323875 , version 1 (05-12-2023)

Identifiers

  • HAL Id : hal-04323875 , version 1
  • WOS : 001023756600832

Cite

Fabien Wauquier, Doriane Ripoche, Line Boutin-Wittrant, Yolanda F Otero, Florian Le Joubioux, et al.. Circulating bioactives resulting from totum-854 absorption in humans protects primary human endothelial cells against lipotoxicity: lessons from an original ex vivo clinical trial. Journal of Hypertension -Supplement-, 2023, 41, pp.E308-E308. ⟨hal-04323875⟩
6 View
0 Download

Share

Gmail Facebook X LinkedIn More